The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions

The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions

Amyloid beta peptide is an important biomarker in Alzheimer’s disease, with the amyloidogenic hypothesis as one of the central hypotheses trying to explain this type of dementia. Despite numerous studies, the etiology of Alzheimer’s disease remains incompletely known, as the pathological accumulatio...

Full description

Bibliographic Details
Main Authors:	Thomas Gabriel Schreiner, Oliver Daniel Schreiner, Maricel Adam, Bogdan Ovidiu Popescu
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Biomedicines
Subjects:	Alzheimer’s disease amyloid beta monomer amyloidogenic pathway biomarker
Online Access:	https://www.mdpi.com/2227-9059/11/5/1411

Similar Items

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
by: Mari Aksnes, et al.
Published: (2021-06-01)

On the border of the amyloidogenic sequences: prefix analysis of the parallel beta sheets in the PDB_Amyloid collection
by: Takács Kristóf, et al.
Published: (2021-07-01)

Relation between serum amylin level and epilepsy
by: Necla Benlier, et al.
Published: (2020-03-01)

The Effect of Ethanol Extract from <i>Mesua ferrea</i> Linn Flower on Alzheimer’s Disease and Its Underlying Mechanism
by: Kusawadee Plekratoke, et al.
Published: (2023-05-01)

Fluorescence-Labeled Amyloid Beta Monomer: A Molecular Dynamical Study
by: János Gera, et al.
Published: (2020-08-01)

Research progress on the intervening effects of active components of Chinese herbs on amyloid-beta-induced injury of neural cells
by: Hang-Xuan Wu, et al.
Published: (2019-01-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era
by: Andrei Surguchov, et al.
Published: (2023-04-01)

Gray matter gamma‐hydroxy‐butyric acid and glutamate reflect beta‐amyloid burden at old age
by: Simon J. Schreiner, et al.
Published: (2024-04-01)

The Alzheimer’s Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides
by: Gabriele Siegel, et al.
Published: (2017-06-01)

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
by: Inge M. W. Verberk, et al.
Published: (2020-09-01)

The Role of Age on Beta-Amyloid1–42 Plasma Levels in Healthy Subjects
by: Chiara Zecca, et al.
Published: (2021-08-01)

The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
by: Abby L. Brand, et al.
Published: (2022-12-01)

Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
by: Thomas Gabriel Schreiner, et al.
Published: (2024-05-01)

The “Cerebrospinal Fluid Sink Therapeutic Strategy” in Alzheimer’s Disease—From Theory to Design of Applied Systems
by: Thomas Gabriel Schreiner, et al.
Published: (2022-06-01)

Inhibitory effect of isoliquiritigenin isolated from Glycyrrhizae Radix on amyloid-β production in Swedish mutant amyloid precursor protein-transfected Neuro2a cells
by: Eun-Ju Yang, et al.
Published: (2015-10-01)

Mechanism of Amyloid Gel Formation by Several Short Amyloidogenic Peptides
by: Oxana V. Galzitskaya, et al.
Published: (2021-11-01)

Nuclear 82-kDa choline acetyltransferase decreases amyloidogenic APP metabolism in neurons from APP/PS1 transgenic mice
by: Shawn Albers, et al.
Published: (2014-09-01)

Beta-amyloid imaging in dementia
by: Kyung Ah Chun
Published: (2018-06-01)

Structural Requirement of hA5G18 Peptide (DDFVFYVGGYPS) from Laminin α5 Chain for Amyloid-like Fibril Formation and Cell Adhesion
by: Guangrui Zhang, et al.
Published: (2022-10-01)

Aducanumab and lecanemab – two novel antibodies against pathologic species of amyloid beta in the treatment of Alzheimer’s disease
by: Jakub Wojcieszak
Published: (2023-05-01)

Dataset of the molecular dynamics simulations of bilayers consisting of short amyloidogenic peptide VDSWNVLVAG from Bgl2p–glucantransferase of S. cerevisiae cell wall
by: Anna V. Glyakina, et al.
Published: (2016-12-01)

Air pollution and plasma amyloid beta in a cohort of older adults: Evidence from the Ginkgo Evaluation of Memory study
by: Anjum Hajat, et al.
Published: (2023-02-01)

Immune cell responses to amyloid-beta proteins: What is the extent and implications of amyloid-beta induced cytotoxicity in microglial cells and peripheral blood mononuclear cells?
by: Cao, A.
Published: (2017-07-01)

Physiological and pathological functions of beta-amyloid in the brain and alzheimer's disease: A review
by: Ladislav Volicer
Published: (2020-01-01)

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics
by: Jurre den Haan, et al.
Published: (2018-08-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
by: Eline A. J. Willemse, et al.
Published: (2021-01-01)

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
by: Guilherme Povala, et al.
Published: (2021-12-01)

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy
by: Kazuto Yamashita, et al.
Published: (2022-06-01)

Amyloid Precursor Protein Changes Arrangement in a Membrane and Its Structure Depending on the Cholesterol Content
by: Vladimir D. Krasnobaev, et al.
Published: (2023-07-01)

Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting
by: Karl Frontzek, et al.
Published: (2016-01-01)

Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study
by: Yuk Yee Leung, et al.
Published: (2015-09-01)

Amyloid beta acts synergistically as a pro-inflammatory cytokine
by: Thomas J. LaRocca, et al.
Published: (2021-11-01)

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
by: Sheng-Min Wang, et al.
Published: (2024-03-01)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
by: Nnana Amakiri, et al.
Published: (2019-05-01)

Aging and Progression of Beta-Amyloid Pathology in Alzheimer’s Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression
by: Cristina Fernández-Mendívil, et al.
Published: (2020-07-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Investigation of the anti-amyloidogenic and antioxidant effects of silver nanoparticles synthesised with leaf extract of Thymus kotschyanus Boiss
by: Zolfaghar Lotfi, et al.
Published: (2023-12-01)

Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology
by: Taewon Kim, et al.
Published: (2022-12-01)

Role of Graphene Oxide in Disentangling Amyloid Beta Fibrils
by: Brianna Duswalt, et al.
Published: (2024-10-01)